Get started
Author

Yun Mai

Observed name: Y. Mai
ORCID: 0000-0002-6011-8874
Observed ORCID: 0000-0002-6011-8874
OpenAlex ID: A5045903507
Optimizing Clinical Trial Eligibility Design Using Natural Language Processing Models and Real-World Data: Algorithm Development and Validation
2024 · Kyeryoung Lee, Zongzhi Liu, et al. · JMIR AI · 16
PDF
CriteriaMapper: establishing the automatic identification of clinical trial cohorts from electronic health records by matching normalized eligibility criteria and patient clinical characteristics
2024 · K. Lee, Y. Mai, et al. · Scientific Reports · 15
PDF
Detecting Ground Glass Opacity Features in Patients With Lung Cancer: Automated Extraction and Longitudinal Analysis via Deep Learning–Based Natural Language Processing
2023 · Kyeryoung Lee, Zongzhi Liu, et al. · JMIR AI · 7
Expression of IMP1 Enhances Production of Murine Leukemia Virus Vector by Facilitating Viral Genomic RNA Packaging
2010 · Yun Mai, Guangxia Gao · PLoS ONE · 6
PDF
Automated Extraction and Longitudinal Analysis of Ground Glass OpacityFeatures in Lung Cancer Patients Powered by Natural Language Processing
2022 · K. Lee, Z. Liu, et al. · American Journal of Respiratory and Critical Care Medicine · 1
Phenotyping of clinical trial eligibility text from cancer studies into computable criteria in electronic health records.
2021 · Yun Mai, Kyeryoung Lee, et al. · Journal of Clinical Oncology · 1
Analyzing treatment patterns and time to the next treatment in chronic lymphocytic leukemia real-world data using automated temporal phenotyping.
2021 · Kyeryoung Lee, Zongzhi Liu, et al. · Journal of Clinical Oncology · 1
Extracting longitudinal anticancer treatments at scale using deep natural language processing and temporal reasoning.
2021 · Meng Ma, Kyeryoung Lee, et al. · Journal of Clinical Oncology · 1
Supplementary Tables from PAK Kinase Inhibition Has Therapeutic Activity in Novel Preclinical Models of Adult T-Cell Leukemia/Lymphoma
2023 · Elaine Y. Chung, Yun Mai, et al.
Supplementary Figures from PAK Kinase Inhibition Has Therapeutic Activity in Novel Preclinical Models of Adult T-Cell Leukemia/Lymphoma
2023 · Elaine Y. Chung, Yun Mai, et al.
Supplementary Materials and Methods from PAK Kinase Inhibition Has Therapeutic Activity in Novel Preclinical Models of Adult T-Cell Leukemia/Lymphoma
2023 · Elaine Y. Chung, Yun Mai, et al.
Data from PAK Kinase Inhibition Has Therapeutic Activity in Novel Preclinical Models of Adult T-Cell Leukemia/Lymphoma
2023 · Elaine Y. Chung, Yun Mai, et al.
Data from PAK Kinase Inhibition Has Therapeutic Activity in Novel Preclinical Models of Adult T-Cell Leukemia/Lymphoma
2023 · Elaine Y. Chung, Yun Mai, et al.
Phenotyping clinical trial treatment regimens in cancer: An integrative ontology, artificial intelligence and knowledge engineering approach.
2020 · Yun Mai, Kyeryoung Lee, et al. · Journal of Clinical Oncology
Representing cancer clinical trial criteria and attributes using ontologies: An NLP-assisted approach.
2020 · Kyeryoung Lee, Zhongzhi Liu, et al. · Journal of Clinical Oncology
Automated abstraction of real-world clinical outcome in lung cancer: A natural language processing and artificial intelligence approach from electronic health records.
2020 · Meng Ma, Arielle Redfern, et al. · Journal of Clinical Oncology
DxTree: a visual analytics tool for hierarchical representation of disease cohort counts for clinical trials.
2020 · Mingwei Zhang, Zongzhi Liu, et al. · AMIA
Works count: 17
Citation count: 48
H-index: 4
I10-index: 2
Year
Topic
Type